Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
16/02/2026
J.P. Morgan raised the target price for Moderna Inc. from $30 to $37.
Latest
3 m ago
Musk predicts that programming will move towards full automation.
5 m ago
Analyst: The revenue growth trajectory of Mrs. Bectors Food Specialties may be improving.
9 m ago
Bridgestone: may repurchase up to 4.7% of the issued shares.
9 m ago
Stone Pharmaceutical Group: GLP-1/GIP receptor dual biased agonist long-acting peptide injection approved for FDA clinical trial.
15 m ago
China Resources Group: Ropivacaine Long-Acting Injection approved to conduct clinical trials in China.
See all latest
